Telemedicine: an Effective and Low-Cost Lesson From the COVID-19 Pandemic for the Management of Heart Failure Patients

Springer Science and Business Media LLC - Tập 20 - Trang 382-389 - 2023
Paolo Severino1, Silvia Prosperi1, Andrea D’Amato1, Claudia Cestiè1, Vincenzo Myftari1, Viviana Maestrini1, Lucia Ilaria Birtolo1, Domenico Filomena1, Marco Valerio Mariani1, Carlo Lavalle1, Roberto Badagliacca1, Massimo Mancone1, Francesco Fedele1, Carmine Dario Vizza1
1Department of Clinical, Internal, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy

Tóm tắt

The purpose of this review is to explore the benefits and controversies that telemedicine (TM), applied to patients with heart failure (HF), can provide in terms of diagnosis, therapeutic management, and prognosis improvement. During the coronavirus disease 19 (COVID-19) outbreak, TM emerged as the most effective and feasible method available to ensure continuous care for chronic diseases. Among these, HF, characterized by high mortality, morbidity, and the need for frequent visits, may benefit of the TM role. HF patients are affected by frequent exacerbations undergoing a progressive prognosis impoverishment, strongly depending on the disease’s management. A precise clinical handling is always required, with a constant optimization of the therapy, a continuous control of risk factors, and a sensitive attention to any change in symptoms, clinical signs, and laboratory tests. In this context, TM has shown to improve therapy adherence and HF: patients’ self-care, impacting the prognosis even if specific results are controversial. Major evidence shows that TM may allow an adequate primary prevention, reducing the impact of the main cardiovascular risk factors. TM can also be useful for the secondary prevention, early detecting a likely HF exacerbation before it becomes clinically manifest, thereby lowering the need for hospitalization. Moreover, an optimal up-titration of the therapy and an increase in treatment adherence are feasible by using TM. However, some studies did not show unambiguous results, and uncertainties still remain.

Tài liệu tham khảo

Conrath DW, et al. An experimental evaluation of alternative communication systems as used for medical diagnosis. Behav Sci. 1975;20(5):296–305.

McDonagh TA, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2021;42(36):3599–726. https://doi.org/10.1093/eurheartj/ehab368.

Wootton R. Chronic disease management telemedicine. In: Trafton JA, Gordon WP, editors. pp 1–20 in Best practices in the behavioral management of chronic disease. Vol II Other medical disorders. Los Altos: Institute for Brain Potential; 2003.

Wootton R. Twenty years of telemedicine in chronic disease management–an evidence synthesis. J Telemed Telecare. 2012;18(4):211–20. https://doi.org/10.1258/jtt.2012.120219.

Severino P, et al. Clinical support through telemedicine in heart failure outpatients during the COVID-19 pandemic period: results of a 12-months follow up. J Clin Med. 2022;11(10):2790.

Silva-Cardoso J, et al. The future of telemedicine in the management of heart failure patients. Cardiac Fail Rev. 2021:7. https://doi.org/10.15420/cfr.2020.32.

Gingele AJ, et al. Integrating avatar technology into a telemedicine application in heart failure patients: a pilot study. Wiener klinischeWochenschrift. 2023: 1–5. https://doi.org/10.1007/s00508-022-02150-8.

Omboni S, et al. The worldwide impact of telemedicine during COVID-19: current evidence and recommendations for the future. Connect Health. 2022;1:7. https://doi.org/10.20517/ch.2021.03.

Nittas V, von Wyl V. COVID-19 and telehealth: a window of opportunity and its challenges. Swiss Med Wkly. 2020;150:20284. https://doi.org/10.4414/smw.2020.20284.

Waters HUGH, Marlon G. The costs of chronic disease in the US. Santa Monica: The Milken Institute; 2018.

Vermeire E, Hearnshaw H, Van Royen P, et al. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001;26:331–42. https://doi.org/10.1046/j.1365-2710.2001.00363.

van Der Wal MHL, et al. Compliance in heart failure patients: the importance of knowledge and beliefs. Eur Heart J. 2006;27(4):434–40. https://doi.org/10.1093/eurheartj/ehi603.

Citoni B, et al. Home blood pressure and telemedicine: a modern approach for managing hypertension during and after COVID-19 pandemic. High Blood Pressure Cardiovasc Prev. 2022;29(1):1-14.22. https://doi.org/10.1007/s40292-021-00492-4.

• Katula JA, et al. Effects of a digital diabetes prevention program: an RCT. Am J Prev Med. 2022; 62(4): 567–577. https://doi.org/10.1016/j.amepre.2021.10.023. Digital Diabetes Prevention Programs demonstrated promising results in improving the lifestyle, notably the weight and HbA1c among people with prediabetes.

Ruberti OM, et al. Hypertension telemonitoring and home-based physical training programs. Blood Press. 2021;30(6):428–38.

Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham study. Circulation. 1979;59(1):8–13.

• Chow CK, Redfern J, Hillis GS, Thakkar J, Santo K, Hackett ML, et al.. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA. 2015; 314(12):1255–1263. https://doi.org/10.1001/jama.2015.10945.2442937. Mobile apps and SMS text messages may encourage the changing of multiple behavioral risk factor, in particular of LDL cholesterol.

Di Lenarda A, et al. The future of telemedicine for the management of heart failure patients: a Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO), the Italian Society of Cardiology (SIC) and the Italian Society for Telemedicine and eHealth (Digital SIT). Eur Heart J Suppl. 2017;19(suppl_D):D113–29.

Bashi N, et al. Remote monitoring of patients with heart failure: an overview of systematic reviews. J Med Internet Res. 2017;19(1):e18.

Koehler F, et al. Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial. Lancet. 2018;392(10152):1047–57.

Ding H, et al. The effects of telemonitoring on patient compliance with self-management recommendations and outcomes of the innovative telemonitoring enhanced care program for chronic heart failure: randomized controlled trial. J Med Internet Res. 2020;22(7): e17559.

Imberti JF, et al. Remote monitoring and telemedicine in heart failure: implementation and benefits. Curr Cardiol Rep. 2021;23:1–11.

• Piro A, Magnocavallo M, Della Rocca DG, Neccia M, Manzi G, Mariani MV, et al. Management of cardiac implantable electronic device follow-up in COVID-19 pandemic: lessons learned during Italian lockdown. J Cardiovasc Electrophysiol. 2020;31: 2814–2823. CIEDs are able to transmit data regarding intrathoracic impedance and early signs of HF allowing the medical team to undertake a timely clinical action.

Magnocavallo M, Bernardini A, Mariani MV, Piro A, Marini M, Nicosia A, Adduci C, Rapacciuolo A, Saporito D, Grossi S, et al. Home delivery of the communicator for remote monitoring of cardiac implantable devices: a multicenter experience during the COVID-19 lockdown. Pacing Clin Electrophysiol. 2021;44:995–1003.

• Abraham WT, et al. Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial. Lancet. 2016; 387(10017): 453–461. Pulmonary artery pressure guided management may lead to a significant reduction in admissions to hospital.

Brugts JJ, et al. Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial. Lancet (2023).

Leclercq C, et al. Wearables, telemedicine, and artificial intelligence in arrhythmias and heart failure: Proceedings of the European Society of Cardiology Cardiovascular Round Table. Europace. 2022; 24(9): 1372–1383.

D’Amario D, Canonico F, Rodolico D, Borovac JA, Vergallo R, Montone RA, Galli M, Migliaro S, Restivo A, Massetti M, Crea F. Telemedicine, artificial intelligence and humanisation of clinical pathways in heart failure management: back to the future and beyond. Card Fail Rev. 2020;6:e16. https://doi.org/10.15420/cfr.2019.17.

Hjorth-Hansen AK, et al. Feasibility and accuracy of tele-echocardiography, with examinations by nurses and interpretation by an expert via telemedicine, in an outpatient heart failure clinic. J Ultrasound Med. 2020;39(12):2313–23.

Magelssen MI, et al. The clinical influence of hand-held ultrasound examinations by general practitioners in patients with suspected heart failure supported by tools for automatic quantification and telemedicine. Eur Heart J-Cardiovasc Imaging. 2022;23(Supplement_1):jeab289-309.

Girerd N, et al. Practical outpatient management of worsening chronic heart failure. Eur J Heart Fail. 2022;24(5):750–61.

Buss VH, et al. Primary prevention of cardiovascular disease and type 2 diabetes mellitus using mobile health technology: systematic review of the literature. J Med Internet Res. 2020;22(10): e21159.

Bae JW, et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR Mhealth Uhealth. 2021;9(9): e29928.

Chaudhry SI, Mattera JA, Curtis JP, Spertus JA, Herrin J, Lin Z, et al. Telemonitoring in patients with heart failure. N Engl J Med. 2010;363:2301–9.

Lindenfeld J, Zile MR, Desai AS, Bhatt K, Ducharme A, Horstmanshof D, et al. Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial. Lancet. 2021;398:991–1001.

Hernandez LS. Role of telemedicine in improving guideline-directed medical treatment for patients with heart failure during a pandemic. Crit Care Nurs Clin N Am. 2022;34(2):151–6. https://doi.org/10.1016/j.cnc.2022.02.004.

• Thibodeau JT, and Gorodeski EZ. Telehealth for uptitration of guideline-directed medical therapy in heart failure. Circulation. 2020; 142(16): 1507–1509. TM has shown to be effective in obtaining an adequate uptitration of HF therapy, improving also therapeutic adherence.

Rao VN, et al. In-hospital virtual peer-to-peer consultation to increase guideline-directed medical therapy for heart failure: a pilot randomized trial. Circ Heart Fail. 2023;16(2):e010158.

Bhatt AS, et al. Virtual optimization of guideline-directed medical therapy in hospitalized patients with heart failure with reduced ejection fraction: the IMPLEMENT-HF pilot study. Eur J Heart Fail. 2021;23(7):1191–201.

Bhatt AS, et al. Virtual care team guided management of patients with heart failure during hospitalization. J Am Coll Cardiol. 2023;81(17):1680–93.

Desai AS, et al. Remote optimization of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction. JAMA Cardiol. 2020;5(12):1430–4.

Gandapur Y, et al. The role of mHealth for improving medication adherence in patients with cardiovascular disease: a systematic review. Eur Heart J-Qual Care Clin Outcomes. 2016;2(4):237–44.

Goldstein CM, et al. Randomized controlled feasibility trial of two telemedicine medication reminder systems for older adults with heart failure. J Telemed Telecare. 2014;20(6):293–9.

Sosa Liprandi MI, Elfman M, Zaidel EJ, Viniegra M, Sosa Liprandi Á. Impact of a telemedicine program after a heart failure hospitalization on 12 months follow-up events. Curr Probl Cardiol. 2023;48(6):101624. https://doi.org/10.1016/j.cpcardiol.2023.101624.

Vellone E, et al. Motivational interviewing to improve self-care in heart failure patients (MOTIVATE-HF): a randomized controlled trial. ESC Heart Fail. 2020;7(3):1309–18.

Koehler F, et al. Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart failure study. Circulation. 2011;123(17):1873–80.

Severino P, et al. Do the current guidelines for heart failure diagnosis and treatment fit with clinical complexity? J Clin Med. 2022;11(3):857. https://doi.org/10.3390/jcm11030857.

Severino P, et al. Heart failure pharmacological management: gaps and current perspectives. J Clin Med. 2023;12(3):1020. https://doi.org/10.3390/jcm12031020.

Jiménez-Marrero S, et al. Impact of telemedicine on the clinical outcomes and healthcare costs of patients with chronic heart failure and mid-range or preserved ejection fraction managed in a multidisciplinary chronic heart failure programme: a sub-analysis of the iCOR randomized trial. J Telemed Telecare. 2020;26(1–2):64–72.

Krzesiński P. Digital health technologies for post-discharge care after heart failure hospitalisation to relieve symptoms and improve clinical outcomes. J Clin Med. 2023;12(6):2373. https://doi.org/10.3390/jcm12062373.

Writing Committee Members; ACC/AHA Joint Committee Members. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. J Card Fail. 2022;28:e1–167.

Stockburger M. Non-device-based telemonitoring: toy or tool? Herzschrittmacherther Elektrophysiol. 2017;28(3):287–92. https://doi.org/10.1007/s00399-017-0525-z.

Zhu Y, Xiang G, Chao X. Effectiveness of telemedicine systems for adults with heart failure: a meta-analysis of randomized controlled trials. Heart Fail Rev. 2020;25:231–43.

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Tập 20

382-389

Thông tin tác giả